Approach to prophylactic measures for central venous catheter-related infections in hemodialysis: A critical review

Hemodialysis International

Volumn 18, Issue 1, 2014, Pages 15-23

  Silva, Tricya N V ^a   de Marchi, Daniel ^a   Mendes, Marcela L ^a   Barretti, Pasqual ^a   Ponce, Daniela ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antibiotic lock therapy; Catheter related bacteremia; Hemodialysis; Tunneled central catheter

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTIMICROBIAL LOCK THERAPY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFECTION PREVENTION; REVIEW; VASCULAR ACCESS;

ANTIBIOTIC LOCK THERAPY; CATHETER-RELATED BACTEREMIA; HEMODIALYSIS; TUNNELED CENTRAL CATHETER;

BACTEREMIA; CENTRAL VENOUS CATHETERS; HUMANS; RENAL DIALYSIS;

EID: 84891902802     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12071     Document Type: Review

References (33)

1. Stevens LA, Stoycheff N, Levey AS. Staging and management of chronic kidney disease. In: Greenberg A, ed. Primer on Kidney Diseases, 5th ed. Philadelphia: Saunders Elsevier. 2009; 436-445.
2. Moist LM, Lee TC, Lok CE, etal. Education in vascular access. Semin Dial. 2013; 26:148-153.
3. Cheung AK, Sarnak MJ, Yan G, etal. Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study. Kidney Int. 2004; 65:2380-2389.
4. Katneni R, Hedayati SS. Central venous catheter-related bacteremia in chronic hemodialysis patients: Epidemiology and evidence-based management. Nat Clin Pract Nephrol. 2007; 3:256-266.
5. Jaber BL. Bacterial infections in hemodialysis patients: Pathogenesis and prevention. Kidney Int. 2005; 67:2508-2519.
6. Liangos O, Gul A, Madias NE, Jaber BL. Long-term management of the tunneled venous catheter. Semin Dial. 2006; 19:158-164.
7. Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access: Update 2006. Am J Kidney Dis. 2006; 48(Suppl 1):S176-S247.
8. O'Grady NP, Alexander M, Dellinger EP, etal. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep. 2002; 51:1-29.
9. Lok CE, Mokrzycki MH. Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int. 2011; 79:587-598.
10. Mermel LA, Allon M, Bouza E, etal. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 49:1-45.
11. Miller DL, O'Grady NP. Guidelines for the prevention of intravascular catheter related infections: Recommendations relevant to interventional radiology for venous catheter placement and maintenance. J Vasc Interv Radiol. 2012; 23:997-1007.
12. Bradburg BD, Fissell RB, Albert JM, etal. Predictors of early mortality among incidents US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007; 2:89-99.
13. Elias RM. Tratamento da Infeccao de Cateter de Hemodialise. In: Cruz J, Barros RT, Kirsztajn GM, and Cruz HMM, eds. Atualidades Em Nefrologia 10. Sao Paulo, Sarvier. 2008; 361-366.
14. O'Grady NP, Alexander M, Burns LA, etal. Summary of recommendations: Guidelines for the prevention of intravascular catheter related infections. Clin Infect Dis. 2011; 52:1087-1099.
15. Al-Solaiman Y, Estrada E, Allon M. The spectrum of infections in catheter-dependent hemodialysis patients. Clin J Am Soc Nephrol. 2011; 6:2247-2252.
16. Betjes MGH. Prevention of catheter-related bloodstream infection in patients on hemodialysis. Nat Rev Nephrol. 2011; 7:257-265.
17. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: A meta-analysis. Ann Intern Med. 2002; 136:792-801.
18. Gilbert RE, Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: A systematic review. Curr Opin Infect Dis. 2008; 21:235-245.
19. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infections: A meta-analysis. JAMA. 1999; 281:261-267.
20. Johnson DW, MacGinley R, Kay TD, etal. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant. 2002; 17:1802-1807.
21. McCann M, Moore ZE. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters. Cochrane Database Syst Rev. 2010; (1):CD006894. doi: 10.1002/14651858.CD006894.pub2.
22. Annigeri R, Conly J, Vas S, etal. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocinn prophylaxis to prevent exit-site infection. Perit Dial Int. 2001; 21:554-559.
23. Kim SH, Song KI, Chang JW, etal. Prevention of uncuffed hemodialysis catheter related bacteremia using an antibiotic lock technique: A prospective, randomized clinical trial. Kidney Int. 2006; 69:161-164.
24. Al-Hwiesh AK, Abdul-Rahman IS. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin. Saudi J Kidney Dis Transpl. 2007; 18:239-247.
25. Mortazavi M, Alsaeidi S, Sobhani R, etal. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime. J Res Med Sci. 2011; 16:303-309.
26. Silva TNV, Mendes ML, Abrao JM, Caramori JT, Ponce D. Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin. Int Urol Nephrol. 2012. doi: 10.1007/s11255-012-0339-1.
27. Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solutions: A meta-analysis of prospective randomized trials. Nephrol Dial Transplant. 2008; 23:166-172.
28. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis. 2008; 51:233-241.
29. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: Systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008; 47:83-93.
30. Snaterse M, Ruger W, Scholte Op Reimer WJ, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: A systematic review of randomized controlled trials. J Hosp Infect. 2011; 75:1-11.
31. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol. 2010; 5:1799-1804.
32. Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B. A randomize trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis. 2012; 59:102-107.
33. Yon CK, Low CL. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters. Am J Health Syst Pharm. 2013; 70:131-136.